Eli Lilly and Company Depositary Receipt

The Eli Lilly and Company Depositary Receipt is a financial instrument traded on the Stock Exchange of Thailand that represents an ownership interest in the American pharmaceutical giant, Eli Lilly and Company. This Depositary Receipt facilitates investment in Eli Lilly by allowing Thai investors to hold shares linked to the company's common stock listed on the New York Stock Exchange. Eli Lilly and Company is a global leader in the pharmaceutical and biotechnology industry, renowned for its development and commercialization of innovative treatments across various therapeutic areas including oncology, diabetes, immunology, and neuroscience. Established in 1876 and headquartered in Indianapolis, Indiana, the company plays a critical role in advancing healthcare worldwide. By providing access to Eli Lilly's equity through Depositary Receipts, the instrument serves as a bridge for international investment, enhancing market liquidity and investment opportunities in the pharmaceutical sector within Thailand.